Ambassador Extraordinary and Plenipotentiary of Uzbekistan to the UK, Ravshan Usmanov met with Nitin Kapoor, Deputy Head of Production Expansion at AstraZeneca, to discuss cooperation between Uzbekistan and the British-Swedish pharmaceutical and biotechnology company.

Nitin Kapoor provided an overview of AstraZeneca’s global activities and highlighted ongoing research initiatives aimed at developing innovative treatments for major diseases, including oncology, cardiovascular conditions, and respiratory disorders. Kapoor emphasized the company’s commitment to expanding its operations in Uzbekistan, leveraging the country’s growing pharmaceutical industry.

Ambassador Usmanov, in turn, discussed the extensive reforms underway in Uzbekistan’s pharmaceutical sector, which aim to attract foreign investment and boost local production capabilities. He outlined the advantages offered to foreign investors, including the commissioning of new production facilities and a favorable business environment. These reforms are expected to create a conducive atmosphere for AstraZeneca to further expand its presence in the country.

The meeting concluded with a mutual agreement to continue strengthening bilateral relations through future meetings and visits, signaling a promising collaboration between Uzbekistan and AstraZeneca.

Founded in 1999 through the merger of Sweden’s Astra AB and the UK’s Zeneca Group, AstraZeneca is headquartered at the Cambridge Biomedical Campus in the UK and employs approximately 90,000 people worldwide. 

The company is renowned for its research and production of drugs addressing critical health issues such as cancer, cardiovascular diseases, gastrointestinal disorders, infectious diseases, neurological conditions, respiratory problems, and inflammatory diseases.